Gene therapy for chronic viral hepatitis: Ribozymes, antisense oligonucleotides, and dominant negative mutants
Open Access
- 1 August 1997
- journal article
- review article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 26 (2), 251-255
- https://doi.org/10.1002/hep.510260237
Abstract
No abstract availableThis publication has 62 references indexed in Scilit:
- Intracellular cleavage of hepatitis C virus RNA and inhibition of viral protein translation by hammerhead ribozymes.Journal of Clinical Investigation, 1996
- A Hitchhiker's Guide to Antisense and Nonantisense Biochemical PathwaysHepatology, 1996
- DNA-Mediated Immunization in Mice Induces a Potent MHC Class I-Restricted Cytotoxic T Lymphocyte Response to the Hepatitis B Envelope ProteinHuman Gene Therapy, 1995
- Targeted delivery of antisense DNA in woodchuck hepatitis virus‐infected woodchucksJournal of Viral Hepatitis, 1995
- Inhibition of Hepatitis C Virus Replication by Antisense Oligonucleotide in Culture CellsBiochemical and Biophysical Research Communications, 1995
- DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibodyHuman Molecular Genetics, 1993
- Cleavage of hepatitis B virus RNA by three ribozymes transcribed from a single DNA templateBiochemical and Biophysical Research Communications, 1992
- Rational design of sequence-specific oncogene inhibitors based on antisense and antigene oligonucleotidesEuropean Journal of Cancer and Clinical Oncology, 1991
- Inhibition of hepatitis B virus by antisense oligodeoxynucleotidesThe Lancet, 1991
- Systematic Evolution of Ligands by Exponential Enrichment: RNA Ligands to Bacteriophage T4 DNA PolymeraseScience, 1990